STOCK TITAN

ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Enzo Biochem, a leader in biosciences and diagnostics, will participate in the 10th Annual LifeSci Partners Corporate Access Event on January 6-8 and 11-14, 2021, alongside J.P. Morgan’s 39th Annual Healthcare Conference. President Barry Weiner and CFO David Bench will host virtual meetings and present a corporate update on January 6 at 1 PM EST. Interested parties can register and listen to the presentation via this link. Enzo Biochem focuses on innovative molecular diagnostics, advancing healthcare with unique technologies.

Loading...
Loading translation...
Argus Session date unavailable
+2.63% session move Open Argus
Details

News Market Reaction – ENZ

The recorded move for ENZ in the trading session of this news was +2.63%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, today announced that it will participate in the 10th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021 in concurrence with J.P. Morgan’s 39th Annual Healthcare Conference.

Barry Weiner, President, and David Bench, Chief Financial Officer, will host virtual 1x1 meetings during both sessions of the event as well as present a corporate update on Wednesday, January 6th at 1pm EST.  

To register or to listen to the presentation as well as to request a meeting, please visit the following registration link: http://lifesci.events/LifeSci2021

About Enzo Biochem
 
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

Forward-Looking Statements

Except for historical information, the matters discussed in this release may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company’s Form 10-K for the fiscal year ended July 31, 2020. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release.

###


Contact:

For Enzo Biochem, Inc.

David Bench, CFO
212-583-0100
dbench@enzo.com

Media:

Marisa Monte       
Berry & Company Public Relations
212-253-8881
mmonte@berrypr.com

Investors:

Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
jeremy@lifesciadvisors.com

Steve Anreder
Anreder & Company
212-532-3232
Steven.anreder@anreder.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Enzo Biochem participating in the LifeSci Partners Corporate Access Event?

Enzo Biochem will participate in the LifeSci Partners Corporate Access Event on January 6-8 and 11-14, 2021.

Who will present for Enzo Biochem at the event?

Barry Weiner, President, and David Bench, CFO, will present for Enzo Biochem.

What is the schedule for Enzo Biochem's corporate update?

Enzo Biochem will present a corporate update on January 6, 2021, at 1 PM EST.

How can I register for the Enzo Biochem presentation?

You can register for the presentation and request a meeting through this registration link.

What are the key areas of focus for Enzo Biochem?

Enzo Biochem specializes in molecular diagnostics by developing innovative diagnostic platform technologies.

Keep reading